<DOC>
	<DOCNO>NCT01865253</DOCNO>
	<brief_summary>This observational proof concept study investigate safety effectiveness renal denervation lower blood pressure people whose blood pressure adequately control due : - intolerance antihypertensive medication - inability take antihypertensive medication due plan pregnancy - renal artery stenosis - chronic kidney disease - non-compliance antihypertensive medication A total 125 participant , 25 group mention recruit study . The duration study 36 month .</brief_summary>
	<brief_title>Renal Denervation Complicated Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>BP ≥140/90 mmHg ( ≥130/80 mmHg patient diabetes ) Intolerance ≥2 antihypertensive drug class Inability take AngiotensinConvertingEnzyme Inhibitor ( ACEI ) , Angiotensin II Receptor Blockers ( ARBs ) Direct Renin inhibitor ( DRIs ) due plan pregnancy Renal artery stenosis Chronic Kidney Disease renal artery anatomy ineligible treatment individual myocardial infarction , unstable angina cerebrovascular accident within 6 month screen visit female participant childbearing potential must negative pregnancy test prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>renal denervation</keyword>
	<keyword>blood pressure</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>target organ damage</keyword>
	<keyword>sympathetic activity</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>non-compliance</keyword>
</DOC>